Biomedical materials are widely used in fields such as surgical repair, physical therapy rehabilitation, and replacement of human tissues or organs, involving multiple medical specialties such as orthopedics, cardiac surgery, neurosurgery, and plastic surgery. In addition, with the continuous development of biotechnology, the application of biomedical materials in drug delivery systems, biodegradable materials, and other fields is becoming increasingly widespread. The biomedical materials industry is a key component of the medical device field, focusing on the research and development, production, and application of materials in the medical field, aiming to replace or repair human tissues and organs, and promote medical and rehabilitation processes. The industry chain covers upstream raw material suppliers, midstream production enterprises, and downstream medical institutions and patients. Upstream provides raw materials such as metals, polymers, and bioceramics; Midstream enterprises process medical materials such as artificial joints and heart valves; The downstream is aimed at medical institutions and patients, achieving clinical applications. With technological innovation and market demand growth, the biomedical materials industry has shown strong development momentum and broad prospects.

With the rapid development of technologies such as the Internet of Things, big data, and artificial intelligence, the biomedical materials industry is gradually moving towards intelligence and remote healthcare. Through the application of intelligent biomedical materials, such as smart drug delivery systems and wearable medical devices, real-time monitoring and remote control of patient physiological parameters can be achieved, improving the convenience and efficiency of medical services. At the same time, the popularization of telemedicine technology has enabled patients to receive professional medical services at home, reducing medical costs and patient burden. The rapid development of biomedical materials industry is driven by multiple factors such as the aging population, the rising incidence rate of chronic diseases and the progress of medical technology. At the same time, policy support, market demand growth, and increased research and development investment also provide strong guarantees for the development of the industry. However, the biomedical materials industry also faces challenges such as high technological barriers, large R&D investment, and fierce market competition. In addition, the improvement of policies and regulations and the expansion of international markets are also important issues that the industry needs to pay attention to.

In recent years, the government has increased its support for the biomedical materials industry and promoted the localization process of high-end products. Through policy guidance, financial support, and industry university research cooperation, domestic enterprises have made significant progress in the research and production of high-end biomedical materials. In the future, with the continuous improvement of domestic enterprises' technological strength and the accumulation of market experience, the localization rate of high-end biomedical materials will further increase, meeting the domestic market demand while gradually moving towards the international market. With the acceleration of globalization and the continuous development of international trade, international cooperation and exchanges in the biomedical materials industry will be further strengthened. Domestic enterprises will expand their overseas markets through participating in international exhibitions and collaborating with multinational corporations; At the same time, we will actively introduce advanced technology and management experience from abroad to enhance our own strength. In addition, international scientific research cooperation will also become closer, jointly promoting technological progress and industrial development in the field of biomedical materials.

The 2025 Shanghai Biomedical Materials Exhibition is a professional exhibition on the theme of new materials industry under the 25th Shanghai International Fair for Industry and Technology. The exhibition area of the previous fair was nearly 300000 square meters, attracting more than 3000 enterprises from more than 50 countries and regions to participate. Through market-oriented, professional, international, and branding operations, it has developed into a certified exhibition through the International Federation of Exhibitions (UFI). The good results of the exhibition have won praise and favor from numerous exhibitors and visitors. This exhibition is about comprehensive solutions for the biomedical materials industry, and is also an international event for professional users and processing in the production of biomedical materials industry. Years of success have established its position as one of the most attractive professional exhibitions in the field of biomedical materials in China and even Asia, providing an ideal business platform for industry peers to meet, gather, and interact. Industry insiders have regarded it as the best platform for "understanding industry information, grasping market trends, showcasing corporate brands, expanding trade channels, and seeking cooperation opportunities".

1、 Biomedical materials:

Biomaterials, Trauma Biomedical Materials 3D printing biomaterials, cardiovascular biomaterials and implants, interventional devices, orthopedic biomedical materials and orthopedic medical implants, bone repair and regeneration materials, cartilage repair and regeneration materials, dental/craniofacial biomaterials, oral tissue regeneration biomaterials, epithelial substitutes biomaterials, ophthalmic biomaterials, neural applications biomaterials, engineering biomaterials for lung research, electrospun nanofiber biomaterials, new tissue repair materials, biomaterials for device drug combinations, nano biomaterials and nanotechnology, bioelectronics and biosensors, marine biomaterials, medical imaging materials and molecular probes, metal materials for medical implants, biomedical polymer materials, bioactive ceramics and glass materials, biomedical composites, and biomedical multi-function gelatinous material Biomaterials for tumor microenvironment regulation, surface/interface characterization, and modified biomaterials.

2、 Basic raw materials for biomedical materials:

Biomimetic structure and function, biological absorption and biological erosion materials, ceramics and glass, composite materials, hydrogels, liposomes, magnetic materials, medical fibers and biological textiles, metals, polymer materials, inorganic non-metallic materials, nanomaterials, natural materials, pollution-free surfaces, physicochemical surface modification, polymer micelles, polymers, proteins and polypeptides, pyrolytic carbon, silicone biomaterials, smart polymers, surface immobilized biomolecules, striated and porous materials, etc.

3、 Preparation and service of biomedical materials:

Biomaterials laboratories, research institutions and universities, biomaterials laboratory supplies, implant processing and manufacturing, 3D printing, etc.

• Company:Shanghai Yewen Exhibition Service Co., Ltd
• Telephone:021-54388602
• Truename:Li Cheng
• Mobile:13122870856
• Address:No. 333 Songze Avenue, Qingpu District, Shanghai (North Gate of the Exhibition Hall)

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870